Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04000061

Heart Failure-USB: Prediction and Progression

Status
Recruiting
Phase
Study type
Observational
Enrollment
6,000 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERmedical chart reviewdata generated by medical review include Medical history, Medications at presentation, during hospitalization and at discharge, New York Heart Association (NYHA) class, Killip class, Electrocardiographic (ECG) data, echocardiographic data, Interventions (Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Graft (CABG), Implantable Cardioverter Defibrillator (ICD) implantation, Cardiac Resynchronization Therapy (CRT) Implantation), Outcome Information: all-cause death, HF hospitalizations
OTHERdata generated by direct IT exportdata generated by direct IT export include Anthropometric data (age, sex, height, weight), Vital signs, Laboratory data

Timeline

Start date
2019-06-13
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2019-06-27
Last updated
2025-04-10

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04000061. Inclusion in this directory is not an endorsement.